Purchase Order 75N91020P00403

<p>The National Cancer Institute issued a purchase order to Molecular Devices LLC for $13,474.00 on April 2, 2020, for a maintenance agreement with an ultimate completion date of April 29, 2021. No set-aside was used. Performance occurs in San Jose, California. The order covers maintenance services on bioanalytical measurement equipment under firm fixed price terms.</p>

<p>The National Cancer Institute awarded a purchase order to Molecular Devices LLC on December 10, 2019, for a maintenance agreement valued at $14,299.00, with completion by December 31, 2020. Work is performed in San Jose, California. The order covers preventive maintenance and performance assurance services for laboratory instrumentation. No set-aside was used.</p>

<p>The National Cancer Institute awarded a purchase order to Molecular Devices LLC for $24,065.00 on June 28, 2018, with ultimate completion June 28, 2019. No set-aside applies. Place of performance is San Jose, California. The order is firm fixed price for laboratory instruments or related equipment and services, consistent with Molecular Devices' core offerings in bioanalytical instrumentation, imaging systems, and associated maintenance.</p>

<p>The National Cancer Institute awarded a purchase order to Molecular Devices LLC for $7,821.75 on March 14, 2019, with an ultimate completion date of March 14, 2020. The order is firm fixed price with no set-aside designation. Place of performance is Gaithersburg, Maryland. The purchase order was issued to de-obligate funds from FY2019 expiring lines in accordance with NIH Office of Administrative Law and Management communication.</p>

<p>The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $10,603.88 firm fixed price purchase order to Molecular Devices LLC for maintenance services. The place of performance will be Molecular Devices' San Jose, California facility. The one year contract starts on December 15, 2023 and ends on December 14, 2024 to support the NIH/NCI's research programs. No subcontractors or set aside designations were identified.</p>

Molecular Devices LLC was awarded a $10,217 firm fixed price purchase order for maintenance services by the National Institutes of Health's National Cancer Institute. The contract has no set-aside designation and work is to be performed in San Jose, California through March 7, 2025. As a provider of bioanalytical measurement solutions, Molecular Devices will support the National Cancer Institute's research efforts through the delivery of maintenance for laboratory instruments and equipment.

The National Cancer Institute awarded a purchase order to Molecular Devices LLC valued at $3,939.00, with an award date of August 31, 2017 and ultimate completion date of September 29, 2017. The order is firm fixed price with no set-aside. Work is performed in Sunnyvale, California. Molecular Devices is a subsidiary of Danaher Corporation (through Beckman Coulter) and supplies specialized bioanalytical laboratory instruments, including microplate readers, high-content imaging systems, and...

The National Cancer Institute awarded a purchase order to Molecular Devices LLC on January 29, 2018, for $9,929.00 firm fixed price, with performance in Bethesda, Maryland and completion by January 31, 2019. The order procures specialized bioanalytical laboratory instruments and associated equipment or services within Molecular Devices' core portfolio of microplate readers, high-content imaging systems, electrophysiology equipment, and maintenance support for federal research applications.

The National Cancer Institute awarded a purchase order to Molecular Devices LLC for $23,525.00 on August 20, 2019, for scientific equipment, with performance scheduled through September 30, 2019. Work is performed in San Jose, California. Molecular Devices, a subsidiary of Danaher Corporation, manufactures bioanalytical laboratory instruments including microplate readers, high-content imaging systems, and electrophysiology equipment sold to federal research agencies on a full-and-open,...

The National Cancer Institute awarded a purchase order to Molecular Devices LLC for $12,249.00 on August 28, 2018, for a one-year service contract covering I3X Plate Reader maintenance and support from September 1, 2018, to August 31, 2019. Performance takes place in San Jose, California. Molecular Devices, a subsidiary of Danaher Corporation, manufactures advanced bioanalytical laboratory instruments and provides associated maintenance and software support to federal research agencies on a...